Institute of Epidemiology and Health Care, UCL, London, WC1E 6BT, UK.
Wolfson Institute of Population Health, Queen Mary University of London, London, UK.
Trials. 2024 Jun 4;25(1):359. doi: 10.1186/s13063-024-08179-6.
Providing supported self-management for people with asthma can reduce the burden on patients, health services and wider society. Implementation, however, remains poor in routine clinical practice. IMPlementing IMProved Asthma self-management as RouTine (IMPART) is a UK-wide cluster randomised implementation trial that aims to test the impact of a whole-systems implementation strategy, embedding supported asthma self-management in primary care compared with usual care. To maximise opportunities for sustainable implementation beyond the trial, it is necessary to understand how and why the IMPART trial achieved its clinical and implementation outcomes.
A mixed-methods process evaluation nested within the IMPART trial will be undertaken to understand how supported self-management was implemented (or not) by primary care practices, to aid interpretation of trial findings and to inform scaling up and sustainability. Data and analysis strategies have been informed by mid-range and programme-level theory. Quantitative data will be collected across all practices to describe practice context, IMPART delivery (including fidelity and adaption) and practice response. Case studies undertaken in three to six sites, supplemented by additional interviews with practice staff and stakeholders, will be undertaken to gain an in-depth understanding of the interaction of practice context, delivery, and response. Synthesis, informed by theory, will combine analyses of both qualitative and quantitative data. Finally, implications for the scale up of asthma self-management implementation strategies to other practices in the UK will be explored through workshops with stakeholders.
This mixed-methods, theoretically informed, process evaluation seeks to provide insights into the delivery and response to a whole-systems approach to the implementation of supported self-management in asthma care in primary care. It is underway at a time of significant change in primary care in the UK. The methods have, therefore, been developed to be adaptable to this changing context and to capture the impact of these changes on the delivery and response to research and implementation processes.
为哮喘患者提供支持性自我管理可以减轻患者、卫生服务和更广泛的社会负担。然而,在常规临床实践中,实施情况仍然不佳。实施改善的哮喘自我管理作为常规(IMPART)是一项英国范围内的集群随机实施试验,旨在测试一种全系统实施策略的影响,即将支持性哮喘自我管理嵌入初级保健中,与常规护理进行比较。为了最大限度地提高试验之外可持续实施的机会,有必要了解 IMPART 试验如何以及为何实现其临床和实施结果。
一项嵌套在 IMPART 试验中的混合方法过程评估将用于了解初级保健实践如何(或未)实施支持性自我管理,以帮助解释试验结果,并为扩大规模和可持续性提供信息。数据和分析策略是根据中程和方案层面的理论制定的。将在所有实践中收集定量数据,以描述实践背景、IMPART 交付(包括保真度和适应性)和实践反应。在三到六个地点进行案例研究,并辅以对实践工作人员和利益相关者的额外访谈,将深入了解实践背景、交付和反应的相互作用。理论指导下的综合分析将结合定性和定量数据分析。最后,通过与利益相关者的研讨会探讨将哮喘自我管理实施策略扩展到英国其他实践的规模。
这项混合方法、理论驱动的过程评估旨在深入了解在初级保健中实施支持性自我管理的整个系统方法的交付和反应。它是在英国初级保健发生重大变化的时候进行的。因此,已经开发了这些方法,以使其适应这种不断变化的背景,并捕捉这些变化对研究和实施过程的交付和反应的影响。